Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurits Wondergem

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Clinical Nuclear Medicine|July 6, 2019
18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mLMaurits Wondergem, Sandra Srbljin, Friso M van der Zant, et al.
Nuclear Medicine Communications|October 22, 2024
Frequency and characteristics of ectopic parathyroid adenomas in a cohort of patients referred for 18 F-fluorocholine PET/CTFriso M van der Zant, Maurits Wondergem, Wouter A M Broos, et al.
World Journal of Nuclear Medicine|September 5, 2022
Incidental Findings on <sup>18</sup> F-Fluorocholine PET/CT for Parathyroid ImagingWouter A M Broos, Remco J J Knol, Friso M van der Zant, et al.
Nuclear Medicine Communications|May 27, 2020
Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidismWouter A M Broos, Maurits Wondergem, Friso M van der Zant, et al.
Clinical Nuclear Medicine|December 7, 2021
Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of SarcoidosisSuzanne J M Tol, Friso M van der Zant, Remco J J Knol, et al.
Nuclear Medicine Communications|October 9, 2025
18F-DCFPyL and 18F-PSMA-JK7 for staging of primary prostate cancer: an interpatient comparison in 500 patientsMaurits Wondergem, Friso M van der Zant, Sergiy V Lazarenko, et al.
Clinical Nuclear Medicine|March 10, 2020
Incidental Breast Carcinoma Detected With 13N-NH3 Cardiac PET ImagingMarie Louise E Bernsen, Friso M van der Zant, Maurits Wondergem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
<sup>18</sup>F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and BiodistributionMaurits Wondergem, Friso M van der Zant, Remco J J Knol, et al.
Oncoimmunology|May 1, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesFrank J Borm, Jasper Smit, Joyce Bakker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2026
Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancerMaarten L Donswijk, Rosemarijn H Ettema, Maurits Wondergem, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Clinical Nuclear Medicine|July 6, 2019
18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mLMaurits Wondergem, Sandra Srbljin, Friso M van der Zant, et al.
Nuclear Medicine Communications|October 22, 2024
Frequency and characteristics of ectopic parathyroid adenomas in a cohort of patients referred for 18 F-fluorocholine PET/CTFriso M van der Zant, Maurits Wondergem, Wouter A M Broos, et al.
World Journal of Nuclear Medicine|September 5, 2022
Incidental Findings on <sup>18</sup> F-Fluorocholine PET/CT for Parathyroid ImagingWouter A M Broos, Remco J J Knol, Friso M van der Zant, et al.
Nuclear Medicine Communications|May 27, 2020
Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidismWouter A M Broos, Maurits Wondergem, Friso M van der Zant, et al.
Clinical Nuclear Medicine|December 7, 2021
Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of SarcoidosisSuzanne J M Tol, Friso M van der Zant, Remco J J Knol, et al.
Nuclear Medicine Communications|October 9, 2025
18F-DCFPyL and 18F-PSMA-JK7 for staging of primary prostate cancer: an interpatient comparison in 500 patientsMaurits Wondergem, Friso M van der Zant, Sergiy V Lazarenko, et al.
Clinical Nuclear Medicine|March 10, 2020
Incidental Breast Carcinoma Detected With 13N-NH3 Cardiac PET ImagingMarie Louise E Bernsen, Friso M van der Zant, Maurits Wondergem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2017
<sup>18</sup>F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and BiodistributionMaurits Wondergem, Friso M van der Zant, Remco J J Knol, et al.
Oncoimmunology|May 1, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesFrank J Borm, Jasper Smit, Joyce Bakker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2026
Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancerMaarten L Donswijk, Rosemarijn H Ettema, Maurits Wondergem, et al.
Pageof 6